0.3601
12.17%
-0.0499
Vorhandelsmarkt:
.37
0.0099
+2.75%
Schlusskurs vom Vortag:
$0.41
Offen:
$0.41
24-Stunden-Volumen:
1.01M
Relative Volume:
1.16
Marktkapitalisierung:
$7.58M
Einnahmen:
$7.19M
Nettoeinkommen (Verlust:
$-50.08M
KGV:
-0.00247
EPS:
-145.9978
Netto-Cashflow:
$-48.33M
1W Leistung:
-9.98%
1M Leistung:
-30.75%
6M Leistung:
-92.56%
1J Leistung:
-93.09%
T 2 Biosystems Inc Stock (TTOO) Company Profile
Firmenname
T 2 Biosystems Inc
Sektor
Branche
Telefon
781-457-1200
Adresse
101 HARTWELL AVENUE, LEXINGTON
Vergleichen Sie TTOO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.3601 | 7.58M | 7.19M | -50.08M | -48.33M | -146.00 |
TMO
Thermo Fisher Scientific Inc
|
544.93 | 208.44B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
238.09 | 171.97B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
137.00 | 39.13B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
204.32 | 37.08B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
432.36 | 35.40B | 3.84B | 866.24M | 792.60M | 10.37 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2021-01-27 | Herabstufung | Alliance Global Partners | Buy → Neutral |
2020-10-08 | Eingeleitet | BTIG Research | Buy |
2019-11-26 | Herabstufung | Janney | Buy → Neutral |
2019-08-01 | Herabstufung | Alliance Global Partners | Buy → Neutral |
2019-07-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2019-07-31 | Herabstufung | Janney | Buy → Neutral |
2019-05-16 | Eingeleitet | Alliance Global Partners | Buy |
2019-03-08 | Bestätigt | H.C. Wainwright | Buy |
2018-06-01 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
2018-05-30 | Bestätigt | H.C. Wainwright | Buy |
2018-05-29 | Bestätigt | WBB Securities | Strong Buy |
2018-03-29 | Bestätigt | H.C. Wainwright | Buy |
2018-01-29 | Eingeleitet | Goldman | Neutral |
2017-10-18 | Eingeleitet | H.C. Wainwright | Buy |
2017-03-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2016-11-10 | Fortgesetzt | Leerink Partners | Mkt Perform |
2016-11-02 | Bestätigt | Cantor Fitzgerald | Buy |
2016-07-20 | Hochstufung | WBB Securities | Buy → Strong Buy |
2016-06-22 | Hochstufung | WBB Securities | Speculative Buy → Buy |
2016-04-12 | Bestätigt | Canaccord Genuity | Buy |
2016-02-17 | Eingeleitet | WBB Securities | Speculative Buy |
Alle ansehen
T 2 Biosystems Inc Aktie (TTOO) Neueste Nachrichten
T2 Biosystems Reports Strong Financial Performance and Strategic Developments - Defense World
T2 Biosystems inks distribution agreement in Baltic region - LabPulse
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
T2 Biosystems Achieves Record Revenue Growth, Expands Global Reach with 27 New Instrument Contracts - StockTitan
T2 Biosystems announces board changes and incentive plan approval - Investing.com India
T2 Biosystems announces board changes and incentive plan approval By Investing.com - Investing.com South Africa
T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com - Defense World
T2 Biosystems Announces Amendments and Voting Results from Annual Meeting**Lexington, Massachusetts – T2 Biosystems, Inc. (NASDAQ: TTOO) recently disclosed significant updates from its recent Annual Meeting with stockholders held on December 3 - Defense World
T2 Biosystems Enhances Governance and Leadership Stability - MSN
T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com - Defense World
T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com - Defense World
T2 Biosystems sells four T2Dx Instruments to European distributor - MSN
T2 Biosystems expands EU presence with instrument sales By Investing.com - Investing.com Australia
Before You Invest, Make Sure You Check This T2 Biosystems Inc (NASDAQ: TTOO) Analysis - Stocks Register
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor - citybiz
T2 Biosystems Expands International Market Presence with Sale of Four T2Dx® Instruments to European Distributor - Nasdaq
T2 Biosystems expands EU presence with instrument sales - Investing.com
T2 Biosystems Expands European Footprint with Strategic T2Dx Instrument Sales, Breakthrough Clinical Data - StockTitan
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally - The Manila Times
T2 Biosystems' Revolutionary Sepsis Tests Hit 250K Milestone, Slash Detection Time by 77 Hours - StockTitan
T2 Biosystems extends Vizient supplier agreement By Investing.com - Investing.com Canada
T2 Biosystems extends Vizient supplier agreement - Investing.com India
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc - Marketscreener.com
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. - The Manila Times
T2 Biosystems (NASDAQ:TTOO) Receives Delisting Notice from Nasdaq**Lexington, Massachusetts-based T2 Biosystems, Inc. (NASDAQ:TTOO) recently disclosed in an 8-K filing with the Securities and Exchange Commission (SEC) that it has received a notif - Defense World
T2 Biosystems stock plunges to 52-week low of $0.41 By Investing.com - Investing.com South Africa
T2 Biosystems faces Nasdaq delisting over share price - Investing.com
T2 Biosystems stock plunges to 52-week low of $0.41 - Investing.com
T2 Biosystems expands its leadership in direct-from-whole-blood detection of sepsis-causing pathogens - SelectScience
T2 Biosystems to license sepsis detection tech By Investing.com - Investing.com Canada
T2 Biosystems to license sepsis detection tech - Investing.com India
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - The Manila Times
T2 Biosystems Announces Plans to License its Proprietary - GlobeNewswire
T2 Biosystems Inc (NASDAQ: TTOO) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World
T2 Biosystems stock plunges to 52-week low of $0.44 By Investing.com - Investing.com Canada
T2 Biosystems stock plunges to 52-week low of $0.44 - Investing.com
T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey
T2 Biosystems: Q3 Earnings Snapshot - mySA
Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com
Earnings call: T2 Biosystems reports growth and strategic partnerships By Investing.com - Investing.com UK
Analysis of ARMISTICE CAPITAL, LLC's Recent Trade in T2 Biosyste - GuruFocus.com
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Finanzdaten der T 2 Biosystems Inc-Aktie (TTOO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):